The following products and services are offered by the subsidiaries of Sekhmet Pharmaventures, namely Anjan Drug Private Limited and Optimus Drugs Private Limited
Amorolfine Cream
Anti-fungal
Strength
0.25% w/w
Route of Administration
Topical Dosage Form
Brivaracetam
Anti-convulsant
Strength
10 mg ,25 mg ,50 mg ,75 mg, & 100 mg
Route of Administration
Oral Dosage Form
Dabigatran Etexilate Capsules
Anti-coagulant
Strength
75 mg, 110 mg and 150 mg
Route of Administration
Oral Dosage Form
Dexlansoprazole Dual Delayed Release Capsules
Proton Pump Inhibitor
Strength
30 mg and 60 mg
Route of Administration
Oral Dosage Form
Eberconazole and Mometasone Furoate Cream
Anti-fungal
Strength
1% and 0.1% w/w
Route of Administration
Topical Dosage Form
Eberconazole Cream
Anti-fungal
Strength
1% w/w
Route of Administration
Topical Dosage Form
Favipiravir Tablets
Anti-viral
Strength
200 mg, 400 mg and 800 mg
Route of Administration
Oral Dosage Form
Fenticonazole Nitrate 2% cream
Anti-fungal
Strength
2% w/w
Route of Administration
Topical Dosage Form
Fenticonazole Nitrate Vaginal Capsules
Anti-fungal
Strength
600 mg Soft Gel
Route of Administration
Infra vaginal Form
Linezolid Tablets IP
Anti-bacterial
Strength
600 mg
Route of Administration
Oral Dosage Form
Luliconazole Cream
Anti-fungal
Strength
1% w/w
Route of Administration
Topical Dosage Form
Luliconazole Lotion
Anti-fungal
Strength
1% w/v
Route of Administration
Topical Dosage Form
Molnupiravir
Covid ā 19
Strength
200 mg, 400 mg and 800 mg
Route of Administration
Oral Dosage Form
Obeticholic Acid Tablets
Choleretic agent
Strength
5 mg and 10 mg
Route of Administration
Oral Dosage Form
Oxiconazole Nitrate Cream
Anti-fungal
Strength
1% w/w
Route of Administration
Topical Dosage Form
Oxiconazole Nitrate Lotion
Anti-fungal
Strength
1% w/v
Route of Administration
Topical Dosage Form
Ozenoxacin
Anti-bacterial
Strength
1%
Route of Administration
Topical Dosage Form
Pirfenidone Tablets IP
Anti-fibrotic
Strength
200 mg
Route of Administration
Oral Dosage Form
Rifaximin Suspension
Anti-biotic
Strength
100 mg / 5 ml
Route of Administration
Oral Dosage Form
Rifaximin Tablets
Anti-biotic
Strength
200 mg, 400 mg and 550 mg
Route of Administration
Oral Dosage Form
Rivaroxaban Tablets
Stroke and Systemic
Strength
2.5 mg, 10 mg, 15 mg and 20 mg
Route of Administration
Oral Dosage Form
Sertaconazole Nitrate + ZPTO Shampoo
Anti-fungal
Strength
2.0% w/v
Route of Administration
Topical Dosage Form
Sertaconazole Nitrate Cream
Anti-fungal
Strength
2.0% w/w
Route of Administration
Topical Dosage Form
Sertaconazole Nitrate Lotion
Anti-fungal
Strength
2.0% w/v
Route of Administration
Topical Dosage Form
Silodosin and Dutasteride Capsules
Bengin Prostatic Hyperplasia (BPH)
Strength
4 mg+0.5 mg and 8 mg +0.5 mg
Route of Administration
Oral Dosage Form
Silodosin Capsules
Bengin Prostatic Hyperplasia (BPH)
Strength
4 mg and 8 mg
Route of Administration
Oral Dosage Form
Tofacitinib
Janus kinase (JAK) inhibitor
Strength
5 mg, 10 mg, 11mg ER and 22 mg ER
Route of Administration
Oral Dosage Form
Ursodeoxycholic Acid Tablets
Biliary Cirrhosis
Strength
150 and 300 mg
Route of Administration
Oral Dosage Form
Vildagliptin
Anti-Diabetic
Strength
50 mg and 100 mg SR
Route of Administration
Oral Dosage Form
Vildagliptin + Metformin
Anti-Diabetic
Strength
50 mg+ 500 mg, 850 mg, 1000 mg, 500 mg SR, 1000 mg SR
Route of Administration
Oral Dosage Form
Aminocaproic acid
Anti-fibrinolytic agent
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Amorolfine
Anti-fungal
DMF
Available
Apixaban
Anti-coagulant
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Bempedoic acid
Lipid Lowering Agents
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Bilastine
Anti-histamine
DMF
Available
Bucillamine
Anti-Inflammatory
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
D-Penicillamine
Anti-Rheumatic
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Dabigatran Etexilate Mesylate
Anti-coagulant
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Dapagliflozin amorphous
Anti-diabetic
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Dapagliflozin propanediol
Anti-diabetic
DMF
Available
Dapoxetine
Anti-Depressant
DMF
Available
Dexlansoprazole
Anti-fungal
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Dimethyl Fumarate
Multiple Sclerosis
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Dithranol
Anti-Psoriatic
Pharmacopeia
EP
EDQM EU
Approved
DMF
Available
Divalproex Sodium
Anti-epileptic
Pharmacopeia
IP, USP
Eberconazole nitrate
Anti-fungal
DMF
Available
Eletriptan hydrobromide
Anti-Migraine
DMF
Available
Empagliflozin
Anti-Diabetic
DMF
Available
Ethacizine Hydrochloride
Anti-Arrhythmic
DMF
Available
Favipiravir
Anti-viral
DMF
Available
Fenticonazole nitrate
Anti-fungal
Pharmacopeia
EP
EDQM EU
Approved
DMF
Available
Gabapentin
Anti-convulsant
Pharmacopeia
USP, ChP, BP, EP, IP
DMF
Available
Linagliptin
Anti-Diabetic
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Linezolid Form I
Anti-Bacterial
DMF
Available
Linezolid Form II
Anti-Bacterial
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Lornoxicam
Anti-Inflammatory
DMF
Available
Luliconazole
Anti-fungal
DMF
Available
Magnesium Valproate
Anti-convulsant
Pharmacopeia
ChP
Mebendazole Form-A
Anti-fungal
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Mesalamine
Aminosalicylates
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Midodrine
Anti-hypotensive
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Molnupiravir
Anti-Viral
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Montelukast
Anti-Allergic
DMF
Available
Nabilone
Anti-Emetic
DMF
Available
Obeticholic acid
Semi-Synthetic Bile Acid
USFDA US
Approved
DMF
Available
Ozenoxacin
Anti-Biotic
DMF
Available
Phenyramidol hydrochloride
Muscle Relaxant
Pharmacopeia
EP
EDQM EU
Approved
DMF
Available
Pirfenidone
Anti-Fibrotic
Pharmacopeia
USP, EP
USFDA US
Approved
EDQM EU
Approved
DMF
Available
Pregabalin
Anti-convulsant
Pharmacopeia
EP, IP, USP
Pregabalin
Anti-Convulsant
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Rifaximin
Anti-Biotic
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Rivaroxaban
Anti-Coagulant
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Rosuvastatin Calcium
Anti-lipemic
DMF
Available
Safinamide
Anti-Parkinson
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Sertaconazole
Anti-Fungal
DMF
Available
Sitagliptin Phosphate
Anti-Diabetic
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Sodium Valproate
Anti- epileptics Anti-convulsant
Pharmacopeia
IP, JP, ChP, BP, EP
Solifenacin succinate
Urinary Disease
Pharmacopeia
USP, EP
DMF
Available
Teriflunomide
Multiple Sclerosis
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Tioconazole
Anti-Fungal
Pharmacopeia
EP
EDQM EU
Approved
DMF
Available
Tofacitinib
Janus kinase (JAK) inhibitor
DMF
Available
Tranylcypromine sulfate
Anti-Depressant
DMF
Available
Valproic Acid
Anti-convulsant
Pharmacopeia
EP, BP
Vildagliptin
Anti-Diabetic
DMF
Available
Zileuton
Anti-Inflammatory
Pharmacopeia
USP
USFDA US
Approved
DMF
Available
Abiraterone
Oncology
Intermediate
(3S,8R,9S,10R,13S,14S)-17-Iodo-10,13-dimethyl-2,3,4,7,8,9,
10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
CAS: 32138-69-5
Intermediate 2
3-Diethylboranyl-pyridine
CAS: 89878-14-8
Apixaban
Anti-coagulant
Intermediate
Ethyl chloro [(4-methoxyphenyl) hydrazono] acetate
CAS: 27143-07-3
Intermediate 2
3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone
CAS: 536760-29-9
Intermediate 3
1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridone
CAS: 1267610-26-3
Intermediate 4
5,6 - dihydro-3-(4-morpholin-yl)-1-(4-nitrophenyl)-2 (1H)-pyridone
CAS: 503615-03-0
Apremilast
Anti-inflammatory
Intermediate
2-(3-ethoxy-4-methoxyphenyl)-1-(methyl sulfonyl)eth-2-ylamine
CAS: 253168-94-4
Intermediate 2
3-Acetamidophthalic anhydride
CAS: 6296-53-3
Atazanavir
Anti-retroviral
Intermediate
Nā-(4-Pyridin-2-yl-benzyl)-hydrazine carboxylic acid butyl ester
CAS: 198904-85-7
Intermediate 2
(2R,3S)-3-tert-butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane
CAS: 98760-08-8
Intermediate 3
N-Methoxycarbonyl-L-tert Leucine
CAS: 162537-11-3
Clobazam
Anti-convulsant
Intermediate
5-chloro-2-nitro-N-phenylaniline
CAS: 25781-92-4
Intermediate 2
Monoethyl malonate potassium salt
CAS: 6148-64-7
Dabigatran Etexylate Mesylate
Anti-coagulant
Intermediate
3-[(3-amino-4-methylamino-benzoyl)-pyridin-2-yl-amino]- propionic acid ethyl ester
CAS: 212322-56-0
Intermediate 2
N-(4-cyanophenyl)-glycine
CAS: 42288-26-6
Eletriptan HBr
Anti-Migraine
Intermediate
(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole
CAS: 143322-57-0
Eltrombopag
Thrombopoietin
Intermediate
3'-Amino-2'-hydroxybiphenyl-3-carboxylic acid
CAS: 376592-93-7
Intermediate 2
2-(3,4-dimethylphenyl)-5-methyl- 2,4-dihydro-3H-pyrazol-3-one
CAS: 277299-70-4
Enzalutamide
Oncology
Intermediate
4-[(2-Cyanopropan-2-yl)amino]-2-fluoro-N-methylbenzamide
CAS: 915087-32-0
Intermediate 2
4-Isothiocyanato-2-(trifluoromethyl)benzo nitrile
CAS: 143782-23-4
Lurasidone
Anti-psychotics
Intermediate
(3aR, 4S, 7R, 7aS)-4,7-methano-1H-isoindole-1,3-(2H)-dione
CAS: 14805-29-9
Intermediate 2
(1R,2R)-1,2-cyclohexanedimethanol
CAS: 65376-05-8
Intermediate 3
(R,R)-1,2-bis(methanesulfonyloxymethyl) cyclohexane
CAS: 186204-35-3
Macitentan
Anti-hypertensive
Intermediate
Propylsulfamide
CAS: 147962-41-2
Intermediate 2
4,6-Dichloro-5-(4-bromophenyl)pyrimidine
CAS: 146533-41-7
Intermediate 3
5-Bromo-2-chloropyrimidine
CAS: 32779-36-5
Mirabegron
Anti-cholinergics
Intermediate
(R)-2-(4-nitrophenyl)ethyl amino)-1-phenylethanol hydrochloride
CAS: 521284-21-9
Intermediate 2
alphaR)-alpha-[[[2-(4-nitrophenyl)ethyl] amino]methyl]benzene methanol
CAS: 223673-34-5
Pirfenidone
Anti-fibrotic
Intermediate
2-Hydroxy-5-methylpyridine
CAS: 1003-68-5
Rivaroxaban
Stroke and Systemic
Intermediate
4-(4-Aminophenyl)morpholin-3-one
CAS: 438056-69-0
Solifenacin Succinate
Urinary Disease
Intermediate
(S)-1-Phenyl-1,2,3,4-Tetrahydro isoquinoline
CAS: 118864-75-8
Teriflunomide
Multiple Sclerosis
Intermediate
5-Methylisoxazole -4-carboxylic acid
CAS: 42831-50-5
As drug molecules get more complex, more innovators and generic manufacturers alike are turning to our CMO/CDMO services, to provide turnkey solutions to streamline their processes and optimize their production. Right from the pre-formulation activities such as development of intermediates, APIs, to development of formulations, conducting and passing Bioequivalence studies and clinical trials, manufacturing of the product as per the regulations of the target market, packaging the product as per guidelines, and bringing products to market whether it is to add a new molecule altogether or a drug variation to their existing product portfolio.
The Sekhmet Pharmaventures group has the unique advantage of being a one stop solution for the entire set of CMO/CDMO requirements. We are vertically integrated with expertise in the entire value chain of drug manufacturing right from Intermediates to final formulations, making the group unprecedented in maintaining quality, timeliness and cost.
Services include :
- IP Evaluation
- Development of Intermediates, APIs
- Formulation
- Analytical Services
- Pilot Bio Studies
- Process Transfer & Scale up Feasibility
- Process Validation
- Analytical Method Verification services
- Stability studies
- Packaging, Serialization and Aggregation
